Volkmar Henschel
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 11
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 5
- Cancer Research top 1%
- Breast Cancer Treatment Studies 4
- Immunology top 2%
-
- Advanced Breast Cancer Therapies 12
- Lung Cancer Treatments and Mutations 4
- Prostate Cancer Treatment and Research 4
-
- Statistical Methods and Inference 4
- Co-authors
- Carlos H. BarriosVéronique DièrasSherene LoiLeisha A. EmensSylvia AdamsHiroji IwataEric P. WinerHope S. Rugo
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (6 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Volkmar Henschel
44 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 4.0k
- Cancer Research 1.2k
- Immunology 1.3k
- Pulmonary and Respiratory Medicine 1.9k
- Complementary and Manual Therapy 87
Countries citing papers authored by Volkmar Henschel
This map shows the geographic impact of Volkmar Henschel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volkmar Henschel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volkmar Henschel more than expected).
Fields of papers citing papers by Volkmar Henschel
This network shows the impact of papers produced by Volkmar Henschel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volkmar Henschel. The network helps show where Volkmar Henschel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Volkmar Henschel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 82 | |
| 2 | First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysisbreakdown → | 2021 | 293 |
| 3 | 2020 | 44 | |
| 4 | 2020 | 8 | |
| 5 | 2020 | 60 | |
| 6 | Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trialbreakdown → | 2019 | 846 |
| 7 | 2018 | 9 | |
| 8 | Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trialbreakdown → | 2015 | 462 |
| 9 | 2010 | 42 | |
| 10 | 2010 | 20 | |
| 11 | 2009 | 49 | |
| 12 | 2008 | 27 | |
| 13 | 2008 | 70 | |
| 14 | 2008 | 42 | |
| 15 | 2008 | 24 | |
| 16 | 2007 | 35 | |
| 17 | 2007 | 5 | |
| 18 | 2006 | 88 | |
| 19 | 2002 | 12 | |
| 20 | Exact distributions in the model of a regression line for the threshold parameter with exponential distribution of errors | 2001 | 2 |
About Volkmar Henschel
Volkmar Henschel is a scholar working on Complementary and Manual Therapy, Oncology and Orthodontics, having authored 44 papers that have together received 5.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (4 papers), Statistical Methods and Inference (4 papers), Breast Cancer Treatment Studies (4 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Oncology (4.0k citations), Cancer Research (1.2k citations) and Immunology (1.3k citations). Volkmar Henschel has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Carlos H. Barrios, Véronique Dièras, Sherene Loi, Leisha A. Emens, Sylvia Adams, Hiroji Iwata, Eric P. Winer, Hope S. Rugo, Luciana Molinero and Jane Yuet Ching Hui. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.